SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-22-006020
Filing Date
2022-04-22
Accepted
2022-04-22 17:00:19
Documents
7
Period of Report
2022-04-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A axsm_2022_proxy_4.xx.22_.htm DEF 14A 1415116
2 GRAPHIC img102416591_0.jpg GRAPHIC 39626
3 GRAPHIC img102416591_1.jpg GRAPHIC 289890
4 GRAPHIC img102416591_2.jpg GRAPHIC 738393
5 GRAPHIC img102416591_3.jpg GRAPHIC 612503
6 GRAPHIC img102416591_4.jpg GRAPHIC 1440444
7 GRAPHIC img102416591_5.jpg GRAPHIC 964335
  Complete submission text file 0000950170-22-006020.txt   7036447
Mailing Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007
Business Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37635 | Film No.: 22846360
SIC: 2834 Pharmaceutical Preparations